The US Food and Drug Administration released a corporate announcement by Kilitch Healthcare India Limited on November 15, 2023.

The announcement states that the company is voluntarily recalling adverse events reported by patients who have used any of its 26 different eye drops nationwide.

The company has notified its distributors, wholesalers, and retailers to report any adverse events following the use of the eye drops, which have an expiration date of November 2023 to September 2025.

As per the report, there has been an issue regarding sterilization during the manufacture of the products.

Due to inadequate and ineffective sterilization, they carry the risk of spreading potential infections.